Lates News
In the early trading on Wednesday, the stock price of genetic testing and precision medicine company Vantage Genetic fell by 4.1%. Earlier reports indicated that the company had reached a partnership agreement with the global leading liquid biopsy company ANGLE plc to advance cancer diagnostics technology.
Latest